ZBH250117C70000
- 0.00
- 0.000.00%
Zimmer Biomet Holdings Newsroom
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $111
NeuroOne Expects Higher Fiscal Q1 Revenue -- Shares Up
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $111
Bernstein Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Cuts Target Price to $122
Bernstein Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Maintains Target Price $130
Zimmer Biomet Holdings (ZBH) Receives a Buy From RBC Capital
71% Of This Zimmer Biomet Holdings Insider's Holdings Were Sold
Express News | Zimmer Biomet Holdings Inc : UBS Cuts Target Price to $105 From $107
Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Raises Target Price to $113
ZBH Stock to Benefit From Global Expansion Despite Macro Issues
Boeing and 6 More Contrarian Stocks for 2025 -- Barrons.com
Boeing and 6 More Contrarian Stocks for 2025
Zimmer Biomet Holdings (ZBH) Gets a Hold From Wells Fargo
2024's 'Biggest Loses' That Could See Reversal in 2025
Returns Are Gaining Momentum At Zimmer Biomet Holdings (NYSE:ZBH)
Zimmer Biomet to Present at the 43rd Annual J.P. Morgan Healthcare Conference
RBC Capital Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Raises Target Price to $130
Zimmer Biomet Holdings To Go Ex-Dividend On December 30th, 2024 With 0.24 USD Dividend Per Share
December 18th (Eastern Time) - $Zimmer Biomet Holdings(ZBH.US)$ is trading ex-dividend on December 30th, 2024.Shareholders of record on December 30th, 2024 will receive 0.24 USD dividend per share
Zimmer Biomet Holdings (NYSE:ZBH) Shareholders Have Endured a 23% Loss From Investing in the Stock Five Years Ago